Preskoči na vsebino

Ortopedska kirurgija

Economic Outcomes

Experience of a network of transfusion coordinators for blood conservation (Ontario Transfusion Coordinators [ONTraC]). (odpre novo okno)

Freedman J, Luke K, Escobar M, Vernich L, Chiavetta JA.

Vir‎: Transfusion 2008;48(2):237-50.

Indeksirano‎: PubMed 18005329

DOI‎: 10.1111/j.1537-2995.2007.01515.x

https://www.ncbi.nlm.nih.gov/pubmed/18005329 (odpre novo okno)

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (odpre novo okno)

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

Vir‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

Indeksirano‎: PubMed 22854336

DOI‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 (odpre novo okno)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (odpre novo okno)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

Vir‎: Int Orthop 2019;43(12):2707-14.

Indeksirano‎: PubMed 30671601

DOI‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (odpre novo okno)

Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (odpre novo okno)

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE.

Vir‎: J Arthroplasty 2014;29(8):1512-5.

Indeksirano‎: PubMed 24630599

DOI‎: 10.1016/j.arth.2014.01.031

https://www.ncbi.nlm.nih.gov/pubmed/24630599 (odpre novo okno)